Indiana 2026 Regular Session

Indiana Senate Bill SB0091

Introduced
12/9/25  
Refer
12/9/25  
Report Pass
1/8/26  
Engrossed
1/28/26  
Refer
1/29/26  
Report Pass
2/10/26  
Enrolled
2/19/26  
Chaptered
3/10/26  

Caption

Syringe exchange program.

Impact

The implementation of SB0091 is expected to positively affect state laws concerning public health and safety. By providing a structured approach to syringe exchange, the bill aims to reduce the transmission of communicable diseases such as HIV and hepatitis among injectable drug users. It empowers local health authorities while mandating oversight by licensed healthcare providers to ensure the programs run in alignment with best practices. Additionally, it stresses the importance of privacy, ensuring no personal information is collected from participants during the syringe exchange process.

Summary

Senate Bill 0091 proposes the establishment and regulation of syringe exchange programs in Indiana, aimed at advancing public health measures to combat drug addiction and its associated harms. The bill allows qualified entities to operate syringe exchange programs under certain conditions, focusing on harm reduction strategies, including the provision of clean syringes and access to overdose intervention drugs. It emphasizes the importance of safe disposal of needles and contamination control, marking a significant legal framework to govern these initiatives within the state.

Sentiment

The sentiment surrounding SB0091 appears divided. Supporters, including various health advocates and public health professionals, argue that the bill represents a necessary step in tackling the ongoing opioid crisis and improving community health outcomes. Conversely, some opponents express concerns regarding the potential normalization of drug use and the establishment of exchanges near schools and childcare centers, raising issues of safety and community standards. This dichotomy reflects broader societal debates on public health strategies versus community moral values.

Contention

Notable points of contention in the discussions around SB0091 include the geographical restrictions placed on syringe exchange sites, particularly concerning their proximity to schools and childcare facilities. Critics argue that such regulations might inhibit access for those in need of services, while supporters believe these safeguards are crucial to maintaining community integrity. Furthermore, the bill's framework for terminating the approval of syringe exchange programs if compliance issues arise has been debated, with some advocating for a more flexible approach to ensure programs can address evolving challenges in public health.

Companion Bills

No companion bills found.

Previously Filed As

IN SB0038

Syringe exchange programs.

IN SB0027

Firearm buyback programs.

IN HB1102

Contracting for preschool programs.

IN SB0118

340B drug program report.

IN SB0386

Community corrections programs.

IN SB0226

Utility customer assistance programs.

IN HB1313

Reentry support pilot programs.

IN HB1476

Funding for child trauma support programs.

IN HB1167

Exceptions to paraphernalia statutes.

IN SB0114

Test strips.

Similar Bills

No similar bills found.